Therapies for metastatic melanoma include the biologic immunotherapy agents ipilimumab, pembrolizumab, and nivolumab; BRAF inhibitors, such as vemurafenib and dabrafenib; and a MEK inhibitor trametinib.
Nodular melanoma
Pseudomelanoma
Lentigo maligna melanoma
Polypoid melanoma
Acral lentiginous melanoma
Amelanotic melanoma
Animal-type melanoma
Superficial spreading melanoma